The Role of Ruxellitinib in HIV Remission

Geneva patient developed graft versus host disease after stem cell transplant. Doctors treated him with a drug called ruxellitinib, which at the time was being investigated for this complication. In November 2021, he went off anti-retroviral therapy for HIV. His viral load remains undetectable. Now researchers want to know whether ruxellitsinib played a role in his recovery.